Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9.12 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 45.81.
Market Cap
9.12T
Revenue
4.59T
Profits
199.02B
PE Ratio
45.81
Profit Margin
4.34%
Dividend Yield
0.38%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.09T | 0.09% | 2,088,205 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 623.71B | -1.63% | 6,425,961 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 441.54B | -1.12% | 5,526,617 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 392.03B | 1.43% | 5,566,701 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 308.90B | -0.73% | 6,989,241 | 65.77B |
| 6 | NVS | Novartis AG | 282.06B | -0.35% | 2,270,249 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 277.49B | -5.70% | 6,648,411 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 216.74B | -0.02% | 5,480,554 | 50.57B |
| 9 | AMGN | Amgen Inc. | 196.25B | -1.19% | 1,728,046 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 194.99B | 2.86% | 1,384,253 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 167.41B | -0.72% | 5,104,729 | 29.74B |
| 12 | ABT | Abbott Laboratories | 164.43B | -0.82% | 8,357,722 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 145.76B | -0.86% | 1,954,197 | 10.58B |
| 14 | DHR | Danaher Corporation | 138.71B | 2.73% | 2,657,340 | 24.78B |
| 15 | PFE | Pfizer Inc. | 138.21B | 0.83% | 29,193,717 | 63.32B |
| 16 | CVS | CVS Health Corporation | 131.18B | -1.59% | 8,474,177 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 126.01B | -0.39% | 2,107,131 | 12.22B |
| 18 | SYK | Stryker Corporation | 125.40B | 0.08% | 1,947,225 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 118.32B | 0.70% | 7,628,670 | 48.48B |
| 20 | MDT | Medtronic plc | 105.46B | 0.46% | 5,540,487 | 36.36B |
| 21 | SNY | Sanofi | 104.93B | 2.62% | 4,100,950 | 54.60B |
| 22 | GSK | GSK plc | 104.61B | -0.10% | 2,358,080 | 43.29B |
| 23 | MCK | McKesson Corporation | 92.82B | -3.16% | 1,005,210 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 91.29B | 1.04% | 1,062,406 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 90.73B | -0.39% | 1,048,265 | 76.39B |
| 26 | CI | The Cigna Group | 77.19B | 0.71% | 1,197,059 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 67.96B | 0.76% | 671,232 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 66.87B | 0.40% | 12,401,399 | 20.61B |
| 29 | COR | Cencora, Inc. | 58.85B | -2.30% | 1,578,935 | 328.68B |
| 30 | ARGX | argenx SE | 56.98B | -0.63% | 287,236 | 4.74B |
| 31 | CAH | Cardinal Health, Inc. | 54.75B | -1.43% | 3,216,440 | 250.74B |
| 32 | MDLN | Medline Inc. | 53.66B | 1.36% | 2,895,367 | 29.14B |
| 33 | EW | Edwards Lifesciences Corporation | 52.59B | -2.47% | 5,578,655 | 6.30B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 52.53B | -0.84% | 2,392,967 | 28.34B |
| 35 | HUM | Humana Inc. | 47.76B | 0.37% | 1,225,963 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.06B | 0.53% | 623,243 | 4.45B |
| 37 | HLN | Haleon plc | 42.54B | -0.41% | 8,420,659 | 14.85B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.76B | -3.31% | 5,886,838 | 4.29B |
| 39 | BDX | Becton, Dickinson and Company | 41.57B | 0.19% | 1,788,624 | 22.23B |
| 40 | RVMD | Revolution Medicines, Inc. | 40.63B | 0.72% | 1,609,900 | - |
| 41 | NTRA | Natera, Inc. | 40.37B | 2.72% | 1,135,018 | 2.50B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 38.54B | -0.42% | 5,112,938 | 17.35B |
| 43 | A | Agilent Technologies, Inc. | 37.73B | 3.50% | 2,372,994 | 7.23B |
| 44 | WAT | Waters Corporation | 37.03B | 2.44% | 534,355 | 3.77B |
| 45 | IQV | IQVIA Holdings Inc. | 34.88B | 2.54% | 1,105,615 | 16.63B |
| 46 | ONC | BeOne Medicines AG | 33.67B | 0.31% | 134,161 | 5.74B |
| 47 | CNC | Centene Corporation | 33.38B | 0.76% | 4,583,509 | 178.33B |
| 48 | RPRX | Royalty Pharma plc | 33.38B | -0.70% | 3,272,548 | 2.44B |
| 49 | ALC | Alcon Inc. | 32.67B | 0.87% | 1,405,949 | 10.63B |
| 50 | ZTS | Zoetis Inc. | 31.48B | -0.03% | 5,611,261 | 9.53B |
| 51 | VEEV | Veeva Systems Inc. | 30.82B | 0.81% | 1,284,710 | 3.32B |
| 52 | MRNA | Moderna, Inc. | 30.38B | 3.74% | 4,411,478 | 2.23B |
| 53 | RMD | ResMed Inc. | 30.07B | 1.27% | 1,479,037 | 5.54B |
| 54 | GEHC | GE HealthCare Technologies Inc. | 29.43B | 0.03% | 3,086,194 | 20.98B |
| 55 | BIIB | Biogen Inc. | 29.37B | -0.72% | 1,657,489 | 9.94B |
| 56 | ILMN | Illumina, Inc. | 29.32B | 3.17% | 1,725,054 | 4.39B |
| 57 | DXCM | DexCom, Inc. | 28.18B | -1.40% | 4,164,360 | 4.82B |
| 58 | ROIV | Roivant Sciences Ltd. | 26.48B | 2.00% | 5,397,846 | 8.26M |
| 59 | PHG | Koninklijke Philips N.V. | 26.03B | -1.16% | 1,068,032 | 20.34B |
| 60 | MTD | Mettler-Toledo International Inc. | 26.03B | 3.13% | 110,226 | 4.09B |
| 61 | INSM | Insmed Incorporated | 25.63B | 1.48% | 3,166,980 | 819.56M |
| 62 | WST | West Pharmaceutical Services, Inc. | 25.27B | 1.13% | 545,481 | 3.22B |
| 63 | INCY | Incyte Corporation | 23.68B | 1.07% | 1,353,556 | 5.36B |
| 64 | BNTX | BioNTech SE | 23.51B | -0.59% | 816,163 | 3.23B |
| 65 | UTHR | United Therapeutics Corporation | 23.45B | -0.34% | 302,775 | 3.17B |
| 66 | DGX | Quest Diagnostics Incorporated | 23.03B | -0.08% | 621,208 | 11.28B |
| 67 | LH | Labcorp Holdings Inc. | 22.77B | -0.04% | 373,292 | 14.14B |
| 68 | GH | Guardant Health, Inc. | 21.76B | 5.06% | 3,849,398 | 1.08B |
| 69 | STE | STERIS plc | 21.05B | 3.11% | 1,300,547 | 5.94B |
| 70 | VTRS | Viatris Inc. | 19.03B | -1.92% | 9,207,660 | 14.56B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 18.15B | 1.30% | 1,178,596 | 3.10B |
| 72 | GMAB | Genmab A/S | 18.12B | 0.81% | 2,770,068 | 3.90B |
| 73 | THC | Tenet Healthcare Corporation | 17.81B | 0.25% | 807,058 | 21.46B |
| 74 | BBIO | BridgeBio Pharma, Inc. | 17.68B | 15.12% | 20,623,618 | 579.96M |
| 75 | ZBH | Zimmer Biomet Holdings, Inc. | 17.26B | 1.91% | 1,809,792 | 8.41B |
| 76 | ASND | Ascendis Pharma A/S | 17.11B | -0.63% | 667,121 | 998.25M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.51B | -0.54% | 713,508 | 4.44B |
| 78 | MEDP | Medpace Holdings, Inc. | 15.29B | 0.66% | 410,574 | 2.68B |
| 79 | BTSG | BrightSpring Health Services, Inc. | 14.91B | 1.53% | 2,048,201 | 13.65B |
| 80 | DVA | DaVita Inc. | 14.73B | -0.54% | 806,069 | 13.84B |
| 81 | EXEL | Exelixis, Inc. | 14.35B | 1.76% | 2,511,635 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.85B | 2.03% | 2,634,746 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.15B | 1.04% | 786,709 | 8.26B |
| 84 | ICLR | ICON Public Limited Company | 12.93B | 1.99% | 525,213 | 8.27B |
| 85 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.91B | -0.95% | 379,018 | 1.13B |
| 86 | AXSM | Axsome Therapeutics, Inc. | 12.81B | 1.38% | 621,686 | 708.24M |
| 87 | SNN | Smith & Nephew plc | 12.77B | 1.50% | 1,398,877 | 6.16B |
| 88 | ALGN | Align Technology, Inc. | 12.76B | 2.00% | 1,086,419 | 4.10B |
| 89 | FMS | Fresenius Medical Care AG | 12.72B | -0.13% | 388,723 | 22.32B |
| 90 | RVTY | Revvity, Inc. | 12.60B | 3.29% | 1,609,064 | 2.90B |
| 91 | PEN | Penumbra, Inc. | 12.51B | 0.21% | 132,917 | 1.45B |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.30B | -0.28% | 3,817,045 | 4.89B |
| 93 | MOH | Molina Healthcare, Inc. | 12.09B | 0.50% | 691,726 | 43.10B |
| 94 | ABVX | ABIVAX Société Anonyme | 12.08B | 1.59% | 907,168 | 5.67M |
| 95 | SMMT | Summit Therapeutics Inc. | 12.01B | -1.34% | 2,365,790 | - |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.83B | -2.03% | 1,437,699 | 622.01M |
| 97 | CYTK | Cytokinetics, Incorporated | 11.69B | 1.40% | 1,655,748 | 105.82M |
| 98 | BAX | Baxter International Inc. | 11.60B | 2.18% | 4,066,516 | 11.32B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 11.59B | 0.37% | 946,749 | 3.24B |
| 100 | CRL | Charles River Laboratories International, Inc. | 11.25B | 4.30% | 652,896 | 4.03B |
| 101 | TECH | Bio-Techne Corporation | 11.09B | 0.27% | 4,715,237 | 1.21B |
| 102 | RDY | Dr. Reddy's Laboratories Limited | 11.08B | -1.63% | 5,124,057 | 3.58B |
| 103 | TEM | Tempus AI, Inc. | 11.04B | 7.39% | 4,636,488 | 1.36B |
| 104 | EHC | Encompass Health Corporation | 11.01B | 0.70% | 843,550 | 6.07B |
| 105 | PODD | Insulet Corporation | 10.96B | 0.53% | 1,069,923 | 2.90B |
| 106 | KRYS | Krystal Biotech, Inc. | 10.94B | -1.11% | 245,594 | 417.30M |
| 107 | IONS | Ionis Pharmaceuticals, Inc. | 10.62B | -23.90% | 20,447,628 | 1.06B |
| 108 | GMED | Globus Medical, Inc. | 10.40B | 0.58% | 2,158,422 | 3.10B |
| 109 | APGE | Apogee Therapeutics, Inc. | 10.01B | 0.24% | 2,057,366 | - |
| 110 | CORT | Corcept Therapeutics Incorporated | 10.01B | 0.33% | 1,189,272 | 769.10M |
| 111 | NUVL | Nuvalent, Inc. | 9.82B | 0.02% | 1,479,241 | - |
| 112 | ENSG | The Ensign Group, Inc. | 9.79B | -0.59% | 414,317 | 5.27B |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.79B | 4.24% | 583,268 | 51.48M |
| 114 | HSIC | Henry Schein, Inc. | 9.55B | 0.77% | 1,180,769 | 13.38B |
| 115 | OSCR | Oscar Health, Inc. | 9.40B | 1.27% | 2,720,295 | 13.30B |
| 116 | UHS | Universal Health Services, Inc. | 9.40B | -0.79% | 647,167 | 17.76B |
| 117 | HALO | Halozyme Therapeutics, Inc. | 9.33B | -2.18% | 1,782,675 | 1.51B |
| 118 | IBRX | ImmunityBio, Inc. | 9.29B | 0.80% | 11,355,717 | 140.98M |
| 119 | PRAX | Praxis Precision Medicines, Inc. | 9.29B | 0.04% | 310,760 | 7.46M |
| 120 | BRKR | Bruker Corporation | 9.22B | 5.89% | 1,602,538 | 3.46B |
| 121 | GKOS | Glaukos Corporation | 9.10B | 1.38% | 781,020 | 551.35M |
| 122 | ALKS | Alkermes plc | 8.96B | -0.94% | 1,630,432 | 1.56B |
| 123 | PTGX | Protagonist Therapeutics, Inc. | 8.85B | -1.73% | 578,116 | 74.06M |
| 124 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.82B | 0.16% | 10,026,831 | 18.07M |
| 125 | QGEN | Qiagen N.V. | 8.68B | 10.50% | 12,745,775 | 2.10B |
| 126 | PCVX | Vaxcyte, Inc. | 8.64B | 1.91% | 1,207,672 | - |
| 127 | SYRE | Spyre Therapeutics, Inc. | 8.58B | 3.51% | 1,329,743 | - |
| 128 | IMVT | Immunovant, Inc. | 8.44B | 1.94% | 998,353 | - |
| 129 | TGTX | TG Therapeutics, Inc. | 8.37B | 3.20% | 1,555,850 | 700.35M |
| 130 | HIMS | Hims & Hers Health, Inc. | 8.21B | -1.72% | 9,262,832 | 2.37B |
| 131 | RGEN | Repligen Corporation | 8.12B | 4.75% | 667,198 | 763.34M |
| 132 | BIO | Bio-Rad Laboratories, Inc. | 7.96B | 4.73% | 225,445 | 2.59B |
| 133 | ATR | AptarGroup, Inc. | 7.94B | 0.19% | 302,085 | 3.87B |
| 134 | HQY | HealthEquity, Inc. | 7.93B | 0.08% | 794,358 | 1.34B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.91B | 0.92% | 586,048 | 217.17M |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 7.79B | -0.68% | 695,519 | 569.61M |
| 137 | PTCT | PTC Therapeutics, Inc. | 7.43B | 1.11% | 1,269,803 | 827.11M |
| 138 | LQDA | Liquidia Corporation | 7.24B | 2.49% | 843,455 | 288.07M |
| 139 | AVTR | Avantor, Inc. | 7.18B | 7.68% | 9,118,042 | 6.55B |
| 140 | HNGE | Hinge Health, Inc. | 6.96B | 1.60% | 1,292,267 | 646.34M |
| 141 | SRRK | Scholar Rock Holding Corporation | 6.94B | 3.41% | 811,309 | - |
| 142 | PACS | PACS Group, Inc. | 6.94B | -0.45% | 498,985 | 5.43B |
| 143 | COGT | Cogent Biosciences, Inc. | 6.92B | 1.35% | 3,868,274 | - |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.90B | -0.71% | 562,602 | 1.55B |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 6.86B | 1.44% | 2,587,138 | 7.50M |
| 146 | CHE | Chemed Corporation | 6.48B | 2.23% | 131,488 | 2.54B |
| 147 | CGON | CG Oncology, Inc. | 6.47B | 5.04% | 776,888 | 5.07M |
| 148 | DFTX | Definium Therapeutics, Inc. | 6.43B | 6.91% | 3,017,564 | - |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 6.39B | 2.45% | 398,301 | 274.48M |
| 150 | GRFS | Grifols, S.A. | 6.21B | -0.27% | 559,264 | 8.58B |
| 151 | BLTE | Belite Bio, Inc | 6.03B | 0.62% | 113,257 | - |
| 152 | BLCO | Bausch + Lomb Corporation | 5.96B | 0.42% | 274,947 | 5.21B |
| 153 | ERAS | Erasca, Inc. | 5.96B | 1.64% | 4,199,736 | - |
| 154 | TFX | Teleflex Incorporated | 5.93B | 2.83% | 531,426 | 2.13B |
| 155 | BLLN | BillionToOne, Inc. | 5.89B | 6.11% | 852,534 | 354.54M |
| 156 | TWST | Twist Bioscience Corporation | 5.83B | 4.80% | 1,263,077 | 409.48M |
| 157 | CELC | Celcuity Inc. | 5.54B | 4.23% | 983,877 | - |
| 158 | TXG | 10x Genomics, Inc. | 5.47B | 15.03% | 2,997,474 | 638.78M |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 5.47B | 2.00% | 2,395,599 | 1.34M |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.44B | 0.19% | 1,428,437 | 536.20M |
| 161 | CRSP | CRISPR Therapeutics AG | 5.43B | -4.83% | 1,436,246 | 4.10M |
| 162 | AMRX | Amneal Pharmaceuticals, Inc. | 5.43B | 0.35% | 1,553,755 | 3.05B |
| 163 | STVN | Stevanato Group S.p.A. | 5.39B | 2.23% | 298,604 | 1.39B |
| 164 | ORKA | Oruka Therapeutics, Inc. | 5.32B | 4.59% | 560,826 | - |
| 165 | LEGN | Legend Biotech Corporation | 5.30B | -1.76% | 1,400,757 | 1.14B |
| 166 | SHC | Sotera Health Company | 5.24B | 5.27% | 3,595,189 | 1.19B |
| 167 | MANE | Veradermics, Incorporated | 5.22B | 5.63% | 315,683 | - |
| 168 | EWTX | Edgewise Therapeutics, Inc. | 5.20B | 4.43% | 1,590,606 | - |
| 169 | RDNT | RadNet, Inc. | 5.19B | 0.53% | 591,056 | 2.14B |
| 170 | CAI | Caris Life Sciences, Inc. | 5.05B | 3.18% | 3,294,445 | 907.29M |
| 171 | INDV | Indivior Pharmaceuticals, Inc. | 5.04B | 1.00% | 1,687,838 | 1.29B |
| 172 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.03B | 0.96% | 746,071 | 754.05M |
| 173 | VKTX | Viking Therapeutics, Inc. | 4.78B | 2.95% | 1,722,342 | - |
| 174 | VCYT | Veracyte, Inc. | 4.73B | 5.67% | 690,657 | 541.74M |
| 175 | LIVN | LivaNova PLC | 4.53B | 0.01% | 612,056 | 1.43B |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 4.52B | 1.58% | 1,729,446 | 1.10B |
| 177 | RLAY | Relay Therapeutics, Inc. | 4.52B | 5.71% | 4,433,256 | 10.68M |
| 178 | WAY | Waystar Holding Corp. | 4.45B | 2.02% | 3,914,444 | 1.16B |
| 179 | TNGX | Tango Therapeutics, Inc. | 4.41B | -0.39% | 2,746,978 | 56.99M |
| 180 | ALHC | Alignment Healthcare, Inc. | 4.35B | 4.99% | 7,055,504 | 4.26B |
| 181 | DNLI | Denali Therapeutics Inc. | 4.32B | 1.95% | 1,567,368 | - |
| 182 | MMSI | Merit Medical Systems, Inc. | 4.26B | 0.56% | 490,936 | 1.54B |
| 183 | MMED | MiniMed Group, Inc. | 4.23B | 0.20% | 480,017 | 3.10B |
| 184 | NAMS | NewAmsterdam Pharma Company N.V. | 4.20B | 0.25% | 884,099 | 22.57M |
| 185 | NVST | Envista Holdings Corporation | 4.19B | 0.08% | 5,029,621 | 2.81B |
| 186 | LFST | LifeStance Health Group, Inc. | 4.19B | 2.96% | 2,649,979 | 1.49B |
| 187 | DOCS | Doximity, Inc. | 4.03B | 1.48% | 1,996,877 | 644.86M |
| 188 | CON | Concentra Group Holdings Parent, Inc. | 4.02B | -0.19% | 653,184 | 2.23B |
| 189 | DYN | Dyne Therapeutics, Inc. | 4.01B | 1.85% | 1,764,439 | - |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.99B | 1.99% | 169,935 | 803.79M |
| 191 | GPCR | Structure Therapeutics Inc. | 3.92B | 0.46% | 459,919 | - |
| 192 | ICUI | ICU Medical, Inc. | 3.91B | 3.05% | 245,369 | 2.16B |
| 193 | IRTC | iRhythm Holdings, Inc. | 3.87B | -5.92% | 699,533 | 787.85M |
| 194 | PBLS | Parabilis Medicines, Inc. | 3.87B | -1.52% | 402,142 | - |
| 195 | ALMS | Alumis Inc. | 3.86B | 1.88% | 2,115,632 | 8.40M |
| 196 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | - | 1,196,368 | 596.96M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.77B | -0.99% | 753,380 | 236.00M |
| 198 | BKD | Brookdale Senior Living Inc. | 3.65B | 1.80% | 3,048,472 | 3.00B |
| 199 | ELVN | Enliven Therapeutics, Inc. | 3.64B | 2.72% | 998,552 | - |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.60B | 0.98% | 1,738,379 | 415.62M |
| 201 | WRBY | Warby Parker Inc. | 3.60B | 5.96% | 1,432,860 | 890.57M |
| 202 | BEAM | Beam Therapeutics Inc. | 3.57B | -2.87% | 2,508,825 | 164.01M |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 3.54B | -1.79% | 983,823 | 225.27M |
| 204 | OGN | Organon & Co. | 3.54B | 0.15% | 1,129,465 | 6.16B |
| 205 | PRVA | Privia Health Group, Inc. | 3.50B | 2.06% | 1,152,076 | 2.25B |
| 206 | ADPT | Adaptive Biotechnologies Corporation | 3.49B | 8.13% | 3,005,961 | 295.41M |
| 207 | HAE | Haemonetics Corporation | 3.41B | 1.60% | 423,985 | 1.33B |
| 208 | OPCH | Option Care Health, Inc. | 3.40B | 0.93% | 2,070,693 | 5.67B |
| 209 | RARE | Ultragenyx Pharmaceutical Inc. | 3.40B | -0.17% | 1,942,584 | 670.00M |
| 210 | NHC | National HealthCare Corporation | 3.35B | 1.13% | 101,106 | 1.53B |
| 211 | GRAL | GRAIL, Inc. | 3.25B | 8.06% | 730,403 | 156.12M |
| 212 | MBX | MBX Biosciences, Inc. | 3.13B | 6.43% | 747,903 | - |
| 213 | ITGR | Integer Holdings Corporation | 3.12B | 0.88% | 405,204 | 1.86B |
| 214 | CLDX | Celldex Therapeutics, Inc. | 3.06B | 0.05% | 612,467 | 865.00K |
| 215 | QURE | uniQure N.V. | 3.06B | 2.28% | 1,160,156 | 18.09M |
| 216 | VERA | Vera Therapeutics, Inc. | 3.05B | 0.05% | 2,751,167 | - |
| 217 | IRON | Disc Medicine, Inc. | 3.02B | -1.40% | 305,555 | - |
| 218 | RGC | Regencell Bioscience Holdings Limited | 3.01B | -6.47% | 600,559 | - |
| 219 | ACHC | Acadia Healthcare Company, Inc. | 2.89B | 2.15% | 2,974,365 | 3.37B |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.83B | -3.35% | 1,296,246 | 776.83M |
| 221 | TARS | Tarsus Pharmaceuticals, Inc. | 2.76B | -5.30% | 2,168,642 | 535.08M |
| 222 | IMNM | Immunome, Inc. | 2.74B | 0.67% | 1,207,033 | 4.02M |
| 223 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.72B | -3.51% | 3,982,332 | 885.72M |
| 224 | KLRA | Kailera Therapeutics, Inc. | 2.72B | -3.45% | 701,550 | - |
| 225 | SLS | SELLAS Life Sciences Group, Inc. | 2.66B | -1.82% | 7,059,507 | - |
| 226 | ESTA | Establishment Labs Holdings Inc. | 2.61B | 0.89% | 303,869 | 229.58M |
| 227 | TRVI | Trevi Therapeutics, Inc. | 2.61B | -1.02% | 1,549,283 | - |
| 228 | GRDN | Guardian Pharmacy Services, Inc. | 2.60B | 1.66% | 305,679 | 1.46B |
| 229 | NRIX | Nurix Therapeutics, Inc. | 2.55B | 1.56% | 1,344,872 | 71.78M |
| 230 | MLYS | Mineralys Therapeutics, Inc. | 2.55B | -4.74% | 1,265,617 | - |
| 231 | AGIO | Agios Pharmaceuticals, Inc. | 2.54B | 0.07% | 520,058 | 66.05M |
| 232 | BHVN | Biohaven Ltd. | 2.53B | 0.90% | 2,101,342 | - |
| 233 | PHVS | Pharvaris N.V. | 2.51B | 0.08% | 1,887,296 | - |
| 234 | KOD | Kodiak Sciences Inc. | 2.50B | -1.35% | 852,006 | - |
| 235 | TMDX | TransMedics Group, Inc. | 2.49B | 2.48% | 568,083 | 635.89M |
| 236 | VCEL | Vericel Corporation | 2.47B | 2.74% | 409,471 | 292.09M |
| 237 | CLOV | Clover Health Investments, Corp. | 2.46B | 0.43% | 4,668,856 | 2.21B |
| 238 | NKTR | Nektar Therapeutics | 2.46B | 1.42% | 692,475 | 55.63M |
| 239 | PGNY | Progyny, Inc. | 2.43B | 1.01% | 1,176,161 | 1.29B |
| 240 | HTFL | HeartFlow, Inc. | 2.39B | 6.00% | 1,061,041 | 191.42M |
| 241 | XRAY | DENTSPLY SIRONA Inc. | 2.38B | 0.93% | 4,058,817 | 3.68B |
| 242 | LMAT | LeMaitre Vascular, Inc. | 2.34B | 0.57% | 177,869 | 256.28M |
| 243 | ASTH | Astrana Health, Inc. | 2.32B | 1.15% | 595,346 | 3.53B |
| 244 | AXGN | Axogen, Inc. | 2.32B | 2.04% | 1,540,235 | 238.11M |
| 245 | OCUL | Ocular Therapeutix, Inc. | 2.31B | 2.63% | 2,429,216 | 52.04M |
| 246 | PBH | Prestige Consumer Healthcare Inc. | 2.30B | 0.39% | 439,455 | 1.09B |
| 247 | ZLAB | Zai Lab Limited | 2.24B | 1.16% | 935,685 | 453.28M |
| 248 | VRDN | Viridian Therapeutics, Inc. | 2.23B | 1.71% | 2,003,036 | 70.92M |
| 249 | ABCL | AbCellera Biologics Inc. | 2.23B | 2.68% | 5,915,679 | 79.21M |
| 250 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21B | 0.34% | 607,825 | 899.11M |
| 251 | SNDX | Syndax Pharmaceuticals, Inc. | 2.20B | 1.14% | 1,441,236 | 217.17M |
| 252 | KARD | Kardigan, Inc. | 2.18B | 10.04% | 247,787 | - |
| 253 | SGRY | Surgery Partners, Inc. | 2.17B | 1.64% | 1,295,999 | 3.34B |
| 254 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | 1.53% | 3,008,296 | 2.18B |
| 255 | PVLA | Palvella Therapeutics, Inc. | 2.17B | 4.03% | 274,652 | - |
| 256 | MD | Pediatrix Medical Group, Inc. | 2.16B | 0.49% | 787,588 | 1.93B |
| 257 | NTLA | Intellia Therapeutics, Inc. | 2.16B | -8.31% | 7,387,646 | 66.09M |
| 258 | ADMA | ADMA Biologics, Inc. | 2.15B | 1.20% | 2,004,489 | 509.86M |
| 259 | AVAH | Aveanna Healthcare Holdings Inc. | 2.14B | 2.40% | 2,411,144 | 2.52B |
| 260 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | 2.22% | 1,589,479 | 298.30M |
| 261 | NUVB | Nuvation Bio Inc. | 2.13B | 4.09% | 8,861,388 | 143.05M |
| 262 | NEOG | Neogen Corporation | 2.12B | 5.29% | 1,445,695 | 870.56M |
| 263 | TSHA | Taysha Gene Therapies, Inc. | 2.10B | 1.23% | 2,227,195 | 7.47M |
| 264 | BFLY | Butterfly Network, Inc. | 2.10B | 9.26% | 9,405,373 | 102.92M |
| 265 | OMCL | Omnicell, Inc. | 2.07B | 1.04% | 593,375 | 1.23B |
| 266 | GLUE | Monte Rosa Therapeutics, Inc. | 2.07B | 1.91% | 1,199,706 | 42.95M |
| 267 | WGS | GeneDx Holdings Corp. | 2.06B | 5.75% | 623,688 | 442.68M |
| 268 | STOK | Stoke Therapeutics, Inc. | 2.04B | 0.55% | 493,778 | 32.08M |
| 269 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.04B | 2.80% | 953,760 | -665.00K |
| 270 | SION | Sionna Therapeutics, Inc. | 2.03B | 2.14% | 697,997 | - |
| 271 | GENB | Generate Biomedicines, Inc. | 2.02B | -0.95% | 503,684 | 30.30M |
| 272 | RAPP | Rapport Therapeutics, Inc. | 2.01B | 0.14% | 312,127 | 20.00M |
| 273 | LKFT | Lakefront Biotherapeutics NV | 2.01B | -0.71% | 119,133 | 1.20B |
| 274 | ADUS | Addus HomeCare Corporation | 2.01B | 3.20% | 420,226 | 1.45B |
| 275 | NVCR | NovoCure Limited | 2.00B | -0.46% | 1,045,613 | 674.41M |
| 276 | RXRX | Recursion Pharmaceuticals, Inc. | 2.00B | 1.08% | 22,293,569 | 66.41M |
| 277 | NBTX | Nanobiotix S.A. | 1.98B | 0.39% | 39,004 | 38.27M |
| 278 | ANAB | AnaptysBio, Inc. | 1.97B | 1.90% | 394,238 | 232.39M |
| 279 | PGEN | Precigen, Inc. | 1.97B | -0.54% | 2,989,079 | 31.60M |
| 280 | TYRA | Tyra Biosciences, Inc. | 1.96B | 1.35% | 612,236 | - |
| 281 | ATAI | AtaiBeckley Inc. | 1.96B | 3.09% | 7,511,667 | 3.49M |
| 282 | URGN | UroGen Pharma Ltd. | 1.96B | 5.78% | 617,918 | 140.49M |
| 283 | HCM | HUTCHMED (China) Limited | 1.96B | -1.26% | 22,086 | 548.51M |
| 284 | IOVA | Iovance Biotherapeutics, Inc. | 1.95B | 2.10% | 13,730,401 | 285.61M |
| 285 | BCAX | Bicara Therapeutics Inc. | 1.95B | 2.38% | 440,070 | - |
| 286 | ABSI | Absci Corporation | 1.94B | 3.33% | 4,970,931 | 1.84M |
| 287 | ZYME | Zymeworks Inc. | 1.94B | 1.58% | 598,095 | 81.26M |
| 288 | UFPT | UFP Technologies, Inc. | 1.93B | -0.72% | 301,476 | 608.85M |
| 289 | AGL | agilon health, inc. | 1.93B | 3.47% | 199,024 | 5.82B |
| 290 | NEO | NeoGenomics, Inc. | 1.92B | 3.44% | 1,517,262 | 745.97M |
| 291 | SNDA | Sonida Senior Living, Inc. | 1.89B | 1.42% | 418,130 | 367.34M |
| 292 | DMRA | Damora Therapeutics, Inc. | 1.89B | 11.81% | 845,623 | - |
| 293 | MESO | Mesoblast Limited | 1.89B | 0.20% | 223,517 | 65.38M |
| 294 | PLSE | Pulse Biosciences, Inc. | 1.89B | -3.09% | 551,890 | 751.00K |
| 295 | GHRS | GH Research PLC | 1.87B | 1.30% | 499,556 | - |
| 296 | ZBIO | Zenas BioPharma, Inc. | 1.86B | 2.29% | 671,144 | 10.00M |
| 297 | ALMR | Alamar Biosciences, Inc. | 1.84B | 4.66% | 192,071 | 87.16M |
| 298 | CMPS | COMPASS Pathways plc | 1.84B | -2.61% | 3,023,427 | - |
| 299 | BHC | Bausch Health Companies Inc. | 1.82B | -1.02% | 1,551,222 | 10.53B |
| 300 | MPLT | MapLight Therapeutics, Inc. | 1.80B | 3.30% | 664,409 | - |
| 301 | MAZE | Maze Therapeutics, Inc. | 1.79B | 1.34% | 584,905 | 20.00M |
| 302 | ANIP | ANI Pharmaceuticals, Inc. | 1.78B | -1.17% | 290,775 | 923.71M |
| 303 | ATRC | AtriCure, Inc. | 1.75B | 2.67% | 940,657 | 552.16M |
| 304 | VIR | Vir Biotechnology, Inc. | 1.74B | -0.86% | 1,285,216 | 65.50M |
| 305 | COAG | Hemab Therapeutics Holdings, Inc. | 1.74B | 9.77% | 313,403 | - |
| 306 | SEPN | Septerna, Inc. | 1.71B | 3.96% | 969,517 | 72.26M |
| 307 | TRLV | Trulieve Cannabis Corp. | 1.70B | -0.56% | 1,121,965 | 1.17B |
| 308 | IMCR | Immunocore Holdings plc | 1.68B | -2.07% | 655,790 | 412.81M |
| 309 | FTRE | Fortrea Holdings Inc. | 1.67B | 3.82% | 971,807 | 2.71B |
| 310 | TDOC | Teladoc Health, Inc. | 1.66B | 1.54% | 2,995,838 | 2.51B |
| 311 | HCSG | Healthcare Services Group, Inc. | 1.66B | 1.00% | 588,061 | 1.85B |
| 312 | MLTX | MoonLake Immunotherapeutics | 1.65B | 4.51% | 1,530,831 | - |
| 313 | INVA | Innoviva, Inc. | 1.64B | -1.03% | 672,063 | 420.69M |
| 314 | INNV | InnovAge Holding Corp. | 1.61B | 3.21% | 156,979 | 949.17M |
| 315 | HROW | Harrow, Inc. | 1.60B | -4.75% | 539,932 | 268.68M |
| 316 | AAPG | Ascentage Pharma Group International | 1.60B | 0.21% | 9,030 | 82.08M |
| 317 | SVRA | Savara Inc. | 1.60B | -1.41% | 1,509,035 | - |
| 318 | AKTS | Aktis Oncology, Inc. | 1.57B | -0.94% | 371,419 | 8.28M |
| 319 | AVBP | ArriVent BioPharma, Inc. | 1.57B | 0.81% | 378,497 | - |
| 320 | KMTS | Kestra Medical Technologies, Ltd. | 1.56B | -0.41% | 387,107 | 83.72M |
| 321 | NVAX | Novavax, Inc. | 1.55B | 0.53% | 2,718,592 | 596.34M |
| 322 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.54B | 3.65% | 1,582,644 | 204.73M |
| 323 | PSNL | Personalis, Inc. | 1.53B | 3.83% | 5,512,609 | 64.52M |
| 324 | INBX | Inhibrx Biosciences, Inc. | 1.52B | 6.95% | 678,696 | 1.30M |
| 325 | CDNA | CareDx, Inc. | 1.50B | 5.66% | 699,766 | 412.82M |
| 326 | XERS | Xeris Biopharma Holdings, Inc. | 1.49B | -0.58% | 2,057,009 | 314.85M |
| 327 | INSP | Inspire Medical Systems, Inc. | 1.48B | 4.50% | 917,111 | 915.25M |
| 328 | ATEC | Alphatec Holdings, Inc. | 1.46B | 3.26% | 1,671,006 | 787.08M |
| 329 | ENOV | Enovis Corporation | 1.45B | 6.73% | 1,973,094 | 2.28B |
| 330 | ARDT | Ardent Health, Inc. | 1.45B | -0.59% | 375,584 | 6.43B |
| 331 | PRGO | Perrigo Company plc | 1.44B | -1.05% | 2,765,539 | 4.18B |
| 332 | IART | Integra LifeSciences Holdings Corporation | 1.43B | 6.30% | 939,722 | 1.64B |
| 333 | PNTG | The Pennant Group, Inc. | 1.41B | 3.21% | 346,456 | 1.02B |
| 334 | OMDA | Omada Health, Inc. | 1.40B | 2.48% | 954,305 | 283.30M |
| 335 | STAA | STAAR Surgical Company | 1.39B | -0.64% | 554,562 | 290.38M |
| 336 | BLFS | BioLife Solutions, Inc. | 1.38B | 3.82% | 557,169 | 101.66M |
| 337 | CRVS | Corvus Pharmaceuticals, Inc. | 1.36B | 0.75% | 1,067,564 | - |
| 338 | IMTX | Immatics N.V. | 1.36B | -0.20% | 280,578 | 43.00M |
| 339 | AHCO | AdaptHealth Corp. | 1.35B | 1.70% | 981,193 | 3.29B |
| 340 | JBIO | Jade Biosciences, Inc. | 1.33B | -0.22% | 646,395 | - |
| 341 | ARDX | Ardelyx, Inc. | 1.33B | -0.92% | 2,171,522 | 427.68M |
| 342 | PAHC | Phibro Animal Health Corporation | 1.31B | -0.18% | 172,772 | 1.50B |
| 343 | CAPR | Capricor Therapeutics, Inc. | 1.30B | 1.12% | 1,169,150 | 11.13M |
| 344 | MGTX | MeiraGTx Holdings plc | 1.29B | -1.41% | 1,149,609 | 79.76M |
| 345 | AVLN | Avalyn Pharma Inc. | 1.28B | -0.07% | 228,660 | - |
| 346 | MNKD | MannKind Corporation | 1.28B | -2.59% | 3,358,418 | 360.78M |
| 347 | AHG | Akso Health Group | 1.28B | -6.88% | 9,440 | 14.84M |
| 348 | NUTX | Nutex Health Inc. | 1.26B | 2.12% | 119,297 | 879.95M |
| 349 | SDGR | Schrödinger, Inc. | 1.25B | 4.35% | 688,184 | 254.91M |
| 350 | IRMD | IRADIMED CORPORATION | 1.25B | 1.80% | 104,005 | 86.28M |
| 351 | EYPT | EyePoint, Inc. | 1.24B | 5.92% | 1,570,801 | 7.61M |
| 352 | AMN | AMN Healthcare Services, Inc. | 1.22B | -1.68% | 781,437 | 3.42B |
| 353 | GMRS | GMR Solutions Inc. | 1.22B | 1.03% | 1,136,274 | 5.83B |
| 354 | WVE | Wave Life Sciences Ltd. | 1.21B | 1.12% | 1,662,963 | 71.80M |
| 355 | XNCR | Xencor, Inc. | 1.19B | -2.10% | 1,245,456 | 97.36M |
| 356 | QDEL | QuidelOrtho Corporation | 1.19B | 1.10% | 1,074,513 | 2.66B |
| 357 | ALVO | Alvotech | 1.18B | -2.35% | 629,021 | 562.04M |
| 358 | SANA | Sana Biotechnology, Inc. | 1.18B | -1.26% | 2,345,415 | - |
| 359 | AZTA | Azenta, Inc. | 1.17B | 3.71% | 591,983 | 596.48M |
| 360 | DRTS | Alpha Tau Medical Ltd. | 1.17B | 1.56% | 407,443 | - |
| 361 | AORT | Artivion, Inc. | 1.17B | 2.25% | 393,508 | 458.69M |
| 362 | LMRI | Lumexa Imaging Holdings, Inc. | 1.17B | 0.16% | 315,116 | 1.03B |
| 363 | AVNS | Avanos Medical, Inc. | 1.17B | 0.08% | 285,312 | 715.90M |
| 364 | COLL | Collegium Pharmaceutical, Inc. | 1.16B | -0.06% | 466,329 | 796.33M |
| 365 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | 0.37% | 880,399 | - |
| 366 | TRAX | First Tracks Biotherapeutics, Inc. | 1.13B | 55.99% | 4,512,544 | - |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 1.13B | -0.27% | 448,129 | - |
| 368 | PRCT | PROCEPT BioRobotics Corporation | 1.12B | -0.25% | 1,540,117 | 322.02M |
| 369 | USPH | U.S. Physical Therapy, Inc. | 1.12B | 4.51% | 194,471 | 787.69M |
| 370 | BIOA | BioAge Labs, Inc. | 1.11B | 5.33% | 588,302 | 10.32M |
| 371 | CNMD | CONMED Corporation | 1.10B | 9.23% | 1,182,872 | 1.37B |
| 372 | SPTX | Seaport Therapeutics, Inc. | 1.10B | -3.53% | 160,057 | - |
| 373 | SLDB | Solid Biosciences Inc. | 1.10B | 1.27% | 1,019,272 | - |
| 374 | OLMA | Olema Pharmaceuticals, Inc. | 1.07B | 0.08% | 1,420,337 | - |
| 375 | KURA | Kura Oncology, Inc. | 1.07B | -0.33% | 1,414,362 | 71.64M |
| 376 | VOR | Vor Biopharma Inc. | 1.07B | -2.76% | 1,597,577 | - |
| 377 | CERT | Certara, Inc. | 1.06B | 3.82% | 2,743,679 | 419.75M |
| 378 | TNDM | Tandem Diabetes Care, Inc. | 1.05B | 1.39% | 1,398,585 | 1.03B |
| 379 | OPK | OPKO Health, Inc. | 1.05B | -1.42% | 2,854,342 | 581.12M |
| 380 | AVTX | Avalo Therapeutics, Inc. | 1.05B | 3.85% | 1,004,132 | 59.00K |
| 381 | CRON | Cronos Group Inc. | 1.04B | 1.09% | 1,043,558 | 159.54M |
| 382 | ETON | Eton Pharmaceuticals, Inc. | 1.02B | 3.21% | 332,503 | 86.93M |
| 383 | JANX | Janux Therapeutics, Inc. | 1.02B | 0.54% | 902,248 | 13.73M |
| 384 | BVS | Bioventus Inc. | 1.02B | 0.91% | 692,659 | 576.30M |
| 385 | ABUS | Arbutus Biopharma Corporation | 1.02B | -1.53% | 2,933,927 | 191.45M |
| 386 | EVO | Evotec SE | 1.01B | 2.16% | 14,659 | 859.03M |
| 387 | PHAR | Pharming Group N.V. | 1.01B | -1.82% | 3,372 | 369.49M |
| 388 | IVA | Inventiva S.A. | 1.01B | 3.19% | 1,782,050 | 7.94M |
| 389 | PCRX | Pacira BioSciences, Inc. | 1.00B | -0.08% | 631,694 | 734.86M |
| 390 | GERN | Geron Corporation | 1.00B | - | 11,741,658 | 196.12M |
| 391 | LXRX | Lexicon Pharmaceuticals, Inc. | 999.44M | -0.88% | 1,465,319 | 69.64M |
| 392 | GDRX | GoodRx Holdings, Inc. | 995.71M | -0.68% | 913,444 | 787.89M |
| 393 | GLAS | Glass House Brands Inc. | 987.72M | 1.04% | 486,849 | 177.68M |
| 394 | ANNX | Annexon, Inc. | 973.22M | -0.34% | 4,004,143 | - |
| 395 | ANRO | Alto Neuroscience, Inc. | 970.00M | 5.94% | 509,391 | - |
| 396 | LBRX | LB Pharmaceuticals Inc | 967.55M | -1.26% | 237,874 | - |
| 397 | PHAT | Phathom Pharmaceuticals, Inc. | 965.87M | 0.83% | 2,167,094 | 204.89M |
| 398 | DBVT | DBV Technologies S.A. | 964.06M | -4.00% | 109,735 | 5.74M |
| 399 | DSGN | Design Therapeutics, Inc. | 963.09M | 0.92% | 644,099 | - |
| 400 | INMD | InMode Ltd. | 951.01M | 3.80% | 1,684,400 | 374.64M |
| 401 | TENX | Tenax Therapeutics, Inc. | 936.00M | 3.33% | 1,532,320 | - |
| 402 | REPL | Replimune Group, Inc. | 932.63M | -0.09% | 2,744,923 | - |
| 403 | AVR | Anteris Technologies Global Corp. | 923.78M | -2.27% | 1,075,118 | 1.85M |
| 404 | FBRX | Forte Biosciences, Inc. | 896.79M | 78.33% | 4,866,521 | - |
| 405 | TBPH | Theravance Biopharma, Inc. | 880.04M | -0.12% | 439,915 | 109.78M |
| 406 | TALK | Talkspace, Inc. | 874.42M | - | 2,391,674 | 238.37M |
| 407 | CTMX | CytomX Therapeutics, Inc. | 861.02M | 3.26% | 2,164,608 | 35.54M |
| 408 | NGNE | Neurogene Inc. | 853.67M | 12.03% | 436,589 | 925.00K |
| 409 | FTH | Faeth Therapeutics, Inc. | 838.84M | 16.13% | 159,154 | - |
| 410 | AMPH | Amphastar Pharmaceuticals, Inc. | 838.65M | 0.74% | 445,929 | 720.53M |
| 411 | OCS | Oculis Holding AG | 827.32M | - | 524,628 | 1.40M |
| 412 | ZVRA | Zevra Therapeutics, Inc. | 824.06M | -5.49% | 1,601,184 | 122.29M |
| 413 | ESPR | Esperion Therapeutics, Inc. | 822.04M | - | 55,349,598 | 418.24M |
| 414 | HSTM | HealthStream, Inc. | 818.61M | -0.57% | 174,724 | 311.78M |
| 415 | RIGL | Rigel Pharmaceuticals, Inc. | 809.65M | 1.93% | 320,107 | 299.77M |
| 416 | RGNX | REGENXBIO Inc. | 809.09M | 2.76% | 1,975,502 | 87.82M |
| 417 | ODTX | Odyssey Therapeutics, Inc. | 805.79M | 8.16% | 167,669 | 1.06M |
| 418 | ACRS | Aclaris Therapeutics, Inc. | 797.48M | 3.63% | 2,047,784 | 8.37M |
| 419 | CLYM | Climb Bio, Inc. | 791.34M | 1.84% | 1,255,148 | - |
| 420 | IMMX | Immix Biopharma, Inc. | 789.50M | 0.82% | 1,447,067 | - |
| 421 | SPRY | ARS Pharmaceuticals, Inc. | 782.51M | -2.72% | 1,155,796 | 98.99M |
| 422 | SIBN | SI-BONE, Inc. | 772.56M | 3.14% | 613,026 | 206.22M |
| 423 | AURA | Aura Biosciences, Inc. | 772.10M | -3.45% | 682,505 | - |
| 424 | IRWD | Ironwood Pharmaceuticals, Inc. | 768.74M | -2.10% | 3,141,607 | 361.51M |
| 425 | GYRE | Gyre Therapeutics, Inc. | 764.81M | - | 61,022 | 117.05M |
| 426 | PRME | Prime Medicine, Inc. | 764.01M | -8.44% | 4,868,531 | 4.03M |
| 427 | DRUG | Bright Minds Biosciences Inc. | 762.82M | 11.91% | 218,808 | - |
| 428 | SSII | SS Innovations International, Inc. | 756.50M | 5.00% | 76,143 | 48.47M |
| 429 | CSTL | Castle Biosciences, Inc. | 744.90M | 3.89% | 262,621 | 339.92M |
| 430 | CBLL | CeriBell, Inc. | 744.82M | 1.19% | 152,285 | 95.07M |
| 431 | OMER | Omeros Corporation | 743.29M | 0.29% | 875,884 | 9.89M |
| 432 | SLBT | SL Science Holding Limited | 737.01M | 5.07% | 62,128 | - |
| 433 | BBNX | Beta Bionics, Inc. | 732.15M | 1.55% | 428,684 | 110.24M |
| 434 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 728.17M | 0.78% | 558,851 | - |
| 435 | ALLO | Allogene Therapeutics, Inc. | 724.82M | -0.94% | 6,544,217 | 22.00K |
| 436 | CADL | Candel Therapeutics, Inc. | 724.64M | 0.10% | 1,101,674 | - |
| 437 | MNPR | Monopar Therapeutics Inc. | 700.02M | 5.27% | 336,753 | - |
| 438 | TCMD | Tactile Systems Technology, Inc. | 692.03M | 2.33% | 120,268 | 343.52M |
| 439 | RLMD | Relmada Therapeutics, Inc. | 682.31M | 1.48% | 1,435,631 | - |
| 440 | CRMD | CorMedix Inc. | 680.18M | -1.81% | 811,405 | 400.05M |
| 441 | FDMT | 4D Molecular Therapeutics, Inc. | 673.84M | -1.00% | 642,519 | 88.24M |
| 442 | SGP | SpyGlass Pharma, Inc. | 671.01M | -1.91% | 136,659 | - |
| 443 | PHR | Phreesia, Inc. | 668.80M | 1.50% | 678,145 | 495.59M |
| 444 | TECX | Tectonic Therapeutic, Inc. | 665.52M | -0.59% | 216,249 | - |
| 445 | ACHV | Achieve Life Sciences, Inc. | 657.02M | 3.06% | 1,721,126 | - |
| 446 | AGMB | AgomAb Therapeutics NV | 641.70M | 2.28% | 54,345 | - |
| 447 | DNA | Ginkgo Bioworks Holdings, Inc. | 635.61M | 7.28% | 1,201,285 | 151.40M |
| 448 | EVH | Evolent Health, Inc. | 633.27M | 0.54% | 1,785,054 | 1.89B |
| 449 | CERS | Cerus Corporation | 631.16M | 0.32% | 1,371,705 | 216.56M |
| 450 | MDXG | MiMedx Group, Inc. | 616.64M | -2.82% | 1,034,983 | 389.42M |
| 451 | EIKN | Eikon Therapeutics, Inc. | 607.44M | 4.66% | 521,522 | - |
| 452 | ALT | Altimmune, Inc. | 606.76M | 0.32% | 2,876,992 | 36.00K |
| 453 | BWAY | BrainsWay Ltd. | 606.60M | 0.87% | 69,390 | 56.22M |
| 454 | NVCT | Nuvectis Pharma, Inc. | 598.67M | 1.28% | 338,143 | - |
| 455 | KYTX | Kyverna Therapeutics, Inc. | 596.40M | -1.01% | 981,841 | - |
| 456 | FLGT | Fulgent Genetics, Inc. | 593.01M | 1.31% | 249,620 | 320.35M |
| 457 | CTKB | Cytek Biosciences, Inc. | 592.76M | 4.56% | 710,954 | 204.17M |
| 458 | TOI | The Oncology Institute, Inc. | 584.90M | 3.54% | 1,992,544 | 545.76M |
| 459 | NPCE | NeuroPace, Inc. | 578.57M | 1.13% | 90,769 | 99.53M |
| 460 | CTNM | Contineum Therapeutics, Inc. | 577.62M | -1.28% | 280,674 | - |
| 461 | MYGN | Myriad Genetics, Inc. | 576.13M | 3.92% | 881,682 | 829.00M |
| 462 | XOMA | XOMA Royalty Corporation | 561.84M | -0.44% | 375,675 | 48.56M |
| 463 | CTEV | Claritev Corporation | 560.87M | 2.75% | 65,027 | 978.76M |
| 464 | CBIO | Crescent Biopharma, Inc. | 556.92M | -0.30% | 168,652 | 11.88M |
| 465 | ASMB | Assembly Biosciences, Inc. | 552.31M | -2.99% | 179,142 | 71.10M |
| 466 | ARVN | Arvinas, Inc. | 551.01M | -0.23% | 456,282 | 89.40M |
| 467 | PROK | ProKidney Corp. | 543.71M | -2.17% | 1,508,432 | 889.00K |
| 468 | STTK | Shattuck Labs, Inc. | 539.06M | 2.18% | 643,597 | 1.00M |
| 469 | WEAV | Weave Communications, Inc. | 538.66M | 0.30% | 821,703 | 248.72M |
| 470 | ANGO | AngioDynamics, Inc. | 538.53M | 0.86% | 265,836 | 313.73M |
| 471 | CLPT | ClearPoint Neuro, Inc. | 536.21M | 3.41% | 349,996 | 40.61M |
| 472 | RZLT | Rezolute, Inc. | 535.91M | 3.43% | 1,407,412 | - |
| 473 | AQST | Aquestive Therapeutics, Inc. | 531.91M | -1.62% | 917,133 | 50.27M |
| 474 | TLRY | Tilray Brands, Inc. | 523.65M | 0.46% | 3,181,439 | 858.28M |
| 475 | ZURA | Zura Bio Limited | 523.44M | 0.36% | 1,103,514 | - |
| 476 | KIDS | OrthoPediatrics Corp. | 519.61M | 2.38% | 52,248 | 243.30M |
| 477 | CABA | Cabaletta Bio, Inc. | 507.92M | -0.48% | 6,365,678 | - |
| 478 | EDIT | Editas Medicine, Inc. | 506.42M | -10.08% | 3,489,907 | 38.69M |
| 479 | PRTA | Prothena Corporation plc | 504.69M | -2.13% | 482,222 | 57.94M |
| 480 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 481 | CYH | Community Health Systems, Inc. | 501.18M | 3.64% | 1,131,893 | 12.29B |
| 482 | PACB | Pacific Biosciences of California, Inc. | 500.07M | 7.33% | 6,137,150 | 160.03M |
| 483 | OCGN | Ocugen, Inc. | 497.63M | -2.00% | 5,451,136 | 4.47M |
| 484 | STRO | Sutro Biopharma, Inc. | 496.95M | -5.81% | 248,219 | 99.61M |
| 485 | VALN | Valneva SE | 495.80M | 0.75% | 9,652 | 180.25M |
| 486 | NNNN | Anbio Biotechnology | 489.39M | -2.96% | 58,133 | 8.65M |
| 487 | NRC | NRC Health | 489.27M | -0.73% | 59,615 | 138.64M |
| 488 | SOPH | SOPHiA GENETICS SA | 488.27M | 5.63% | 374,365 | 81.18M |
| 489 | PRLD | Prelude Therapeutics Incorporated | 486.96M | -4.10% | 309,224 | 16.72M |
| 490 | EVMN | Evommune, Inc. | 486.61M | 1.96% | 1,444,535 | 10.00M |
| 491 | OVID | Ovid Therapeutics Inc. | 485.26M | -4.76% | 1,859,958 | 7.12M |
| 492 | VSTM | Verastem, Inc. | 474.52M | 6.30% | 5,131,389 | 49.59M |
| 493 | CCCC | C4 Therapeutics, Inc. | 474.33M | 2.39% | 2,536,283 | 34.86M |
| 494 | VMD | Viemed Healthcare, Inc. | 470.01M | 0.99% | 253,293 | 286.57M |
| 495 | DCTH | Delcath Systems, Inc. | 466.73M | 3.21% | 333,553 | 90.44M |
| 496 | SLN | Silence Therapeutics plc | 465.73M | -0.90% | 232,687 | 839.00K |
| 497 | OFIX | Orthofix Medical Inc. | 464.04M | -0.52% | 272,850 | 825.37M |
| 498 | BNTC | Benitec Biopharma Inc. | 463.10M | - | 56,991 | - |
| 499 | RCKT | Rocket Pharmaceuticals, Inc. | 457.52M | -1.18% | 2,855,533 | - |
| 500 | ARTV | Artiva Biotherapeutics, Inc. | 457.21M | 1.07% | 261,160 | 251.00K |